Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Goldman Sachs said in a Friday note that a cooling of geopolitical tensions could allow global equities to resume recent outperformance and put downward pressure on the U.S. dollar. The bank argued markets are currently balancing high inflation against weak growth while pricing in risks from the Iran conflict and a possible sustained energy shock. …
Profound Medical Corp. announced that Texas Prostate, led by Dr. James Cochran, has reached the milestone of performing 100 TULSA Procedures using Profound's TULSA-PRO system at Dallas Medical Center. The collaboration has increased procedure volume by 500% since transitioning to a Medicare payment model, accelerating adoption of this innovative, M…
Goldman Sachs downgraded Beiersdorf (ETR:BEIG) from Buy to Neutral following FY25 results, trimming earnings forecasts and reducing its FY26 revenue estimate to €9.86 billion. The bank flagged decelerating NIVEA sales, weakness at La Prairie and margin headwinds driven by raw material costs, foreign exchange and limited operating leverage. It also …
Clearmind Medicine Inc., a Nasdaq-listed clinical-stage biotech company, announced the filing of a patent application in India for next-generation psychedelic compounds aimed at treating mental health disorders and addiction. This move expands the company's global intellectual property portfolio and builds on its licensing agreement with Yissum Res…
Social media and prediction markets have lit up around the prospect of a SpaceX public offering, with users placing millions of dollars on the likely ticker, listing venue and valuation. Market wagers, shifting odds for a single-letter ticker, and discussions about an unusually large retail allocation underscore the unusual investor focus on the pr…
Streamex Corp. clarifies and disproves misleading third-party reports about the expiration of lock-up agreements related to its January 2026 financing. The company confirms that the previous lock-ups of certain shares held by co-founders Henry McPhie and Morgan Lekstrom were shorter than reported and that newly agreed voluntary one-year lock-ups ha…
Bank of America views the recent pullback in semiconductor memory stocks — triggered by headlines around Google's TurboQuant compression technology — as an overreaction. The bank's analysts say AI capital expenditure remains the primary signal of memory demand and point to rising memory on next-generation chips, increased cloud capex guidance and h…
Early economic effects from the Iran war are surfacing in Britain, with surging gas prices and downgrades to growth and inflation forecasts constraining both monetary and fiscal policymakers. The combination of higher energy costs, falling consumer confidence, and limited fiscal headroom raises difficult trade-offs for the Bank of England and the g…
Benchmark U.S. Treasury yields rose to their strongest levels since July as oil prices resumed an upward trajectory and investors processed news that the White House extended its deadline for possible strikes on Iranian energy infrastructure. The advance in yields came despite the announced extension and against a backdrop of tightened expectations…
Jefferies recommends selective purchases in the paper and packaging sector after a broad sell-off tied to the Iran war and related energy-market disruptions. The group has fallen about 14% since the conflict began. The firm outlines how Amcor, Crown Holdings and Ball Corporation are positioned to manage higher input costs through scale, pass-throug…
Goldman Sachs adjusted its coverage of several Italian banks, upgrading Intesa Sanpaolo to buy with a €6.9 price target and 36% upside, downgrading Banco BPM to neutral, and initiating coverage of Banca Monte dei Paschi di Siena and BPER Banca at buy and neutral respectively. The moves rest on changes to profit and capital forecasts, valuation comp…
Rocket Pharmaceuticals saw its stock climb after the U.S. Food and Drug Administration gave accelerated approval to KRESLADI, an autologous hematopoietic stem cell-based gene therapy for pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I) who lack an HLA-matched sibling donor for allogeneic transplant. The approval is based on bi…
The Bank of Spain estimates first-quarter GDP rose between 0.5% and 0.6%, a deceleration from 0.8% in Q4. It raised its baseline growth forecast for 2026 to 2.3% from 2.2%, factoring in the economic effects of the war in Iran. The central bank also adjusted inflation and public finance projections while noting that energy price and external market …
Sportradar Group AG, a leading global sports technology company, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC. The report is available to investors via the company’s website and SEC filings. Sportradar provides technology and services to sports federations, media, and betting opera…
SFL Corporation Ltd., a maritime shipping company listed on the NYSE, announced its Annual General Meeting to be held on May 11, 2026, with voting record date set for April 1, 2026. The company highlighted its stable dividend record since 2004 and provided a cautionary statement about risks and uncertainties affecting its business including market …
ParaZero Technologies Ltd. announced a successful transformation in 2025 from a drone safety components supplier to a leading Tier 1 defense provider specializing in multi-layered autonomous counter-unmanned aerial systems (C-UAS). The company reported a 12% year-over-year revenue growth in 2025, with early 2026 orders already exceeding the full pr…
Aurora Mobile has entered into a strategic partnership with Soochow Securities to integrate its intelligent push notification platform, JPush, into Soochow Securities' 'Dongwu Xiucai' mobile app. This collaboration aims to improve real-time, secure delivery of financial notifications and personalized client communication, advancing Soochow's digita…
Satellos Bioscience Inc. reported significant progress in 2025, including closing a $57.2 million equity financing, commencing Nasdaq trading under ticker MSLE, and initiating two Phase 2 clinical trials (BASECAMP and TRAILHEAD) for its lead candidate SAT-3247 targeting Duchenne muscular dystrophy (DMD). Clinical data showed maintained or improved …
Legence Corp. reported record quarterly revenues of $737.6 million for Q4 2025, a 34.6% increase year-over-year, driven mainly by organic growth. The company posted a 53% increase in quarterly Adjusted EBITDA and a 49% increase in total backlog and awarded contracts to $3.7 billion. Strategic acquisitions including Bowers and Metrix enhance its mar…
Autolus Therapeutics reported fourth quarter and full year 2025 financial results highlighted by $74.3 million in net product revenue for their CAR T cell therapy AUCATZYL, approved for relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). The company has launched AUCATZYL in the UK following positive NICE evaluation and expects conti…
DoubleDown Interactive Co., Ltd., a developer and publisher of digital games, announced the results of its 2026 Annual General Meeting. Shareholders approved the 18th financial statements for 2025, elected two independent directors, approved amendments to the Articles of Incorporation, and set remuneration limits for independent directors and execu…
Werewolf Therapeutics announced its Q4 and full-year 2025 financial results, highlighting a reduced net loss and operational expenses compared to 2024. The company revealed its decision to explore strategic alternatives, including potential sale, merger, or collaborations to maximize shareholder value. With $57.1 million in cash at year-end, they e…
Humacyte, Inc. announced its financial results for Q4 and full year 2025 with revenues of $0.5 million and $2.0 million respectively, driven by the commercial launch of Symvess in the US and strategic international expansion efforts. The company secured a $1.475 million purchase commitment from Saudi Arabia for clinical evaluation and is pursuing r…
Radiopharm Theranostics has dosed the first patient in its Phase 1 clinical trial of RAD 402, a monoclonal antibody radiolabeled with Terbium-161, targeting KLK3 for advanced prostate cancer. The trial aims to assess safety, tolerability, biodistribution, and preliminary efficacy, with data from initial dose levels expected by mid-2026. Preclinical…
Equity markets showed limited improvement after U.S. President Donald Trump delayed his deadline on Iran, according to a note from Vital Knowledge. Analyst Adam Crisafulli said the deferment did not spark a broad equity rebound as investors remain anxious about the situation. Reports that the Pentagon may add roughly 10,000 troops to the Middle Eas…
